These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36047786)

  • 1. Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
    Negatu DA; Zimmerman MD; Dartois V; Dick T
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0079022. PubMed ID: 36047786
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
    Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
    Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against
    Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA
    mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
    Pozuelo Torres M; van Ingen J
    Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Fröberg G; Ahmed A; Chryssanthou E; Davies Forsman L
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0052823. PubMed ID: 37671880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in
    Le Terrier C; Nordmann P; Bouvier M; Poirel L
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0054723. PubMed ID: 37668385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection.
    Negatu DA; González Del Río R; Cacho-Izquierdo M; Barros-Aguirre D; Lelievre J; Rullas J; Casado P; Ganapathy US; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0145922. PubMed ID: 36688684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
    Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Lactamase inhibition by avibactam in Mycobacterium abscessus.
    Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M
    J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The
    Andersson V; Fröberg G; Dahl VN; Chryssanthou E; Giske C; Schön T; Forsman LD
    Int J Mycobacteriol; 2023; 12(3):211-225. PubMed ID: 37721224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

  • 16. The addition of avibactam renders piperacillin an effective treatment for
    Meir M; Bifani P; Barkan D
    Antimicrob Resist Infect Control; 2018; 7():151. PubMed ID: 30564307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex.
    Misawa K; Nishimura T; Kashimura S; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Hasegawa N
    Int J Antimicrob Agents; 2022; 60(5-6):106669. PubMed ID: 36064079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the β-Lactamase Bla
    Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem.
    Le Run E; Atze H; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
    Sayed ARM; Shah NR; Basso KB; Kamat M; Jiao Y; Moya B; Sutaria DS; Lang Y; Tao X; Liu W; Shin E; Zhou J; Werkman C; Louie A; Drusano GL; Bulitta JB
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.